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a  b  s  t  r  a  c  t
Canine  parvovirus  type  2 (CPV-2),  including  subtypes  2a, 2b and  2c, causes  an  acute  enteric  disease  in  both
domestic  and  wild  animals.  Rapid  and  sensitive  diagnosis  aids effective  disease  management  at points  of
need (PON).  A commercially  available,  ﬁeld-deployable  and user-friendly  system,  designed  with  insulated
isothermal  PCR  (iiPCR)  technology,  displays  excellent  sensitivity  and  speciﬁcity  for  nucleic  acid  detection.
An  iiPCR  method  was  developed  for on-site  detection  of all circulating  CPV-2  strains.  Limit  of detection
was  determined  using  plasmid  DNA.  CPV-2a,  2b  and  2c  strains,  a feline  panleukopenia  virus  (FPV)  strain,
and  nine  canine  pathogens  were  tested  to  evaluate  assay  speciﬁcity.  Reaction  sensitivity  and  performance
were  compared  with an in-house  real-time  PCR  using  serial  dilutions  of  a  CPV-2b  strain  and  100  canine
fecal  clinical  samples  collected  from  2010  to  2014,  respectively.  The  95% limit of  detection  of the  iiPCR
method  was  13  copies  of  standard  DNA  and detection  limits  for CPV-2b  DNA  were  equivalent  for  iiPCR
and  real-time  PCR.  The  iiPCR  reaction  detected  CPV-2a,  2b  and  2c  and  FPV.  Non-targeted  pathogens  were
not detected.  Test  results  of real-time  PCR  and  iiPCR  from  99  fecal  samples  agreed  with  each  other,  while
one  real-time  PCR-positive  sample  tested  negative  by  iiPCR.  Therefore,  excellent  agreement  (k  =  0.98)
with  sensitivity  of  98.41%  and speciﬁcity  of  100%  in  detecting  CPV-2  in  feces  was  found  between  the  two
methods.  In conclusion,  the iiPCR  system  has  potential  to serve  as a useful  tool  for rapid  and  accurate
PON,  molecular  detection  of CPV-2.
ublis© 2015  The  Authors.  P
Canine parvovirus type 2 (CPV 2) is a non-enveloped, single
tranded DNA virus belonging to the species Carnivore pro-
oparvovirus 1, which also includes feline parvovirus (feline
anleukopenia virus), mink enteritis virus, and raccoon parvovirus
18-A. This species, with associated viruses, is a member of the
enus Protoparvovirus, subfamily Parvovirinae, family Parvoviridae
Cotmore et al., 2014). CPV-2 has been reported to be a highly conta-
ious pathogen of domestic dogs and other members of the family
anidae worldwide (reviewed by Desario et al., 2005). Unlike other
NA viruses, CPV-2 evolved rapidly and current genetic variants
nclude CPV-2a, CPV-2b, and CPV-2c strains (Buonavoglia et al.,
Abbreviations: CPV-2, canine parvovirus type 2; FAM, 6-carboxyﬂuorescein; FPV,
eline panleukopenia virus; iiPCR, insulated isothermal PCR; MGB, minor groove
inder group; POCKITTM, POCKITTM Nucleic Acid Analyzer; PON, point of need; qPCR,
eal-time PCR; UTVMC, University of Tennessee Veterinary Medical Center.
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166-0934/© 2015 The Authors. Published by Elsevier B.V. This is an open access article uhed  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).
2000; Clegg et al., 2011). The currently circulating strains can also
infect domestic cats and can cause severe disease and death in cats,
just as feline panleukopenia does. CPV-2 infection causes myocardi-
tis in the fetuses of dogs infected in late gestation and also in
infected neonates lacking maternally derived antibodies (Carpenter
et al., 1980; Hayes et al., 1979). The most common problem in dogs
between weaning and 6 months is enteritis (Houston et al., 1996;
Parrish et al., 1982; Pollock and Coyne, 1993), with clinical signs of
lethargy, anorexia, vomiting and hemorrhagic diarrhea. Parvovirus
also causes leukopenia, with lymphopenia and neutropenia due to
infection and damage to the bone marrow (Houston et al., 1996).
Mortality rates may  be high in puppies (Pollock and Coyne, 1993).
The virus is spread through the fecal-oral route. Fomites con-
taining virus-laden fecal material are a common source of infection
because dogs shed billions of virions or more per gram of feces
during the height of infection and CPV-2 is highly stable in the envi-
ronment for many months (Decaro et al., 2005b). CPV-2 is shed in
the feces of infected dogs within 4–5 days prior to the onset of clin-
ical symptoms, throughout the period of illness, and up to several
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table 2
Analytical sensitivity analysis of CPV-2 iiPCR using plasmid DNA.
Copies/reaction Total Positive Rate (%) Avg. SD
NTC 20 0 0 0.98 0.03
100  10 10 100 4.04 0.36
50  20 20 100 2.86 0.73
10  20 15 75 3.9 0.77
5  10 8 80 2.98 0.96
T
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eeks after clinical recovery (Decaro et al., 2005a). Cats can also
hed CPV-2 and may  have in-apparent infection. Such cats would
lso be a source of infection for in-contact dogs.
Because CPV-2 is highly contagious and can cause severe disease
nd death, a sensitive and speciﬁc diagnostic test is essential to help
etect small amounts of parvovirus shed in the stool from dogs in
cute stages of infection, during recovery from the disease, or from
ogs that are subclinical shedders. These dogs are a source of infec-
ion for contact animals in animal shelters, veterinary hospitals, or
n breeding facilities, and are an important source of environmen-
al contamination (Gordon and Angrick, 1986). Rapid identiﬁcation
nd isolation of CPV-2-positive animals at these stages of infection
ould help timely implementation of proper supportive treatment
f the patient and reduce CPV-2 spread among the population.
Some diagnostic tests lack the sensitivity to detect CPV-2 in
tool samples, despite clinical signs and postmortem ﬁndings that
re supportive of a CPV-2 diagnosis (Parrish et al., 1982; Studdert
t al., 1983). The most commonly used in-house SNAP test (IDEXX;
estbrook, MA,  USA) for CPV-2 diagnosis can only detect CPV-2 in
amples with >105 virion equivalents per milligram of feces (Decaro
t al., 2010). A sensitive test would help conﬁrm a CPV-2 diagno-
is based on clinical signs, in the absence of a positive in-house
LISA result (Decaro et al., 2010). Situations like this, in some cases
ith high virus titers, have happened with signiﬁcant frequency,
o the recommended approach for parvovirus diagnosis is to use
he in-house assay ﬁrst, followed by testing with a more sensitive
olecular method (such as PCR) in questionable cases (Decaro et al.,
010). Nested PCR (Hirasawa et al., 1994) and real-time PCR (qPCR)
ssays (Decaro et al., 2005b) have been shown to be highly sen-
itive tests. However, application of nested and qPCR assays has
een limited to professional laboratories due to their requirement
f experienced technicians and costly equipment.
An on-site highly sensitive molecular test for CPV-2 diagno-
is would enable appropriate quarantine and disease management
f infected dogs, besides helping cut down sample shipping and
rocessing costs and shorten test turnaround time. The newly
eveloped convection PCR method, termed insulated isothermal
CR (iiPCR) (Tsai et al., 2012), provides this capability. It util-
zes a hydrolysis probe (similar to Taq-man based qPCR) and
uns in a commercially available device, POCKITTM Nucleic Acid
nalyzer (POCKITTM; GeneReach USA, Lexington, MA,  USA). The
eaction mixture is automatically passed sequentially through
ifferent temperature zones in a capillary tube that is placed
ithin the device to complete the 3 stages (denaturation, anneal-
ng, and extension) required for PCR. Optical signals produced by
robe hydrolysis during the reaction are converted to S/N ratios
signalafter/signalbefore) by a data processing module and automat-
cally reported as positive/negative results on a display screen. The
eaction takes approximately 1 h to complete and is user-friendly
nough to be run by animal shelter personnel or clinical technical
taff. The device can be operated with a rechargeable battery or car
attery. The small size (28 cm × 25 cm × 8.5 cm,  W × D × H), light
eight (2.1 kg), and ruggedness enable the POCKITTM iiPCR device
o be ﬁeld deployable. Excellent sensitivity and speciﬁcity of iiPCR
ystems in detecting target pathogens from clinical samples have
able 1
rimer and probe sequences used in CPV-2 iiPCR and qPCR.
Reaction Primer/probe name Sequence (5′ to 3′) 
CPV-2 iiPCR CPV F2 GTTAACGGAAACATGGCTTTAG
CPV  R1 TAGTTGCCAATCTCCTGGATTAA
CPV  probe FAM-CCCCAAGCATTTGCATCA-
CPV-2 qPCR Parvo forward GACGACAGCACAGGAAACAA 
Parvo reverse CTGGTTGTGCCATCATTTCA 
Parvo probe FAM-TCACCTGAAGACTGGATG
a Based on GenBank Accession number JQ268284.NTC, no template control.
95% hit rate was  10.725 by Probit analysis.
been reported for different DNA and RNA viruses, such as white
spot syndrome virus in shrimp, equine inﬂuenza virus in horses,
and canine distemper virus in dogs (Balasuriya, 2014; Balasuriya
et al., 2014; Tsai et al., 2014; Wilkes et al., 2014).
In this study, taking advantage of the iiPCR system with the
ﬁeld-deployable POCKITTM device, a reaction was  developed to
detect CPV-2 at points of need (PON). The primer/probe set
was designed to target a highly conserved region within the
VP2 genes of CPV-2 strains available in GenBank, based on the
recommended principles for iiPCR (http://www.iipcr.com/eweb/
uploadﬁle/20130522114104277.pdf). The probe was labeled with
a ﬂuorescent reporter dye (6-carboxyﬂuorescein, FAM) at the
5′ end and a minor groove binder group (MGB) with a non-
ﬂuorescent quencher at the 3′ end (Applied Biosystems, Foster
City, CA, USA). The optimized iiPCR included 0.5 M forward
primer, 0.5 M reverse primer, 0.05 M probe (Table 1), 26 U of
Taq DNA polymerase (BioMi, Taichung, Taiwan), and 1× Uni-ii HS
Buffer (GeneReach USA) and generated an amplicon of 111 bp. The
primers, probe, dNTP, and Taq were lyophilized and rehydrated
with 50 l of reconstitution buffer (GeneReach USA) before use.
After mixing with 5 l of sample nucleic acid, 50 l of the mix-
ture was  transferred to a capillary R-tubeTM (GeneReach USA). The
tube was spun brieﬂy in a CubeeTM mini centrifuge (GeneReach
USA) and placed into the commercial iiPCR device for reaction. A
lyophilized positive control (plasmid DNA), provided with the kit,
was reconstituted and used for each run, and water was used as a
negative control for each run. Serial dilutions of a standard plasmid
DNA, which contained the target sequence, were tested in 10 or
20 repeats to evaluate detection limit of the iiPCR. Limit of detec-
tion 95% was  determined to be 13 copies of standard DNA by probit
analysis (Table 2).
No gold standard method exists currently to detect CPV-2 in
fecal samples. To evaluate the performance of iiPCR-POCKITTM
reagent in detecting CPV-2 in fecal samples, side-by-side compar-
ison with that of the in-house qPCR routinely used at University
of Tennessee Veterinary Medical Center (UTVMC) was performed.
Fecal samples were prepared by mixing with a 1:1 volume of PBS
and supernatant was  used for DNA extraction using QIAamp DNA
Mini Kit (Qiagen, Valencia, CA, USA) according to manufacturer’s
instructions. Primers and probe of the CPV-2 qPCR were designed
with Primer 3 (Rozen and Skaletsky, 2000) to target a 158-bp frag-
ment in a highly conserved region of the NS1 gene (Table 1). Five l
of DNA samples were run in 25-l total volume reactions using
Premix Ex Taq Probe qPCR (Clontech, Mountain View, CA, USA)
Nucleotide locationa Target gene
ATGA 3052–3077 VP2
AC 3138–3162
MGB-NFQ 3114–3131
1062–1081
1200–1219 NS1
ATGTTACAACCA-BHQ1 1159–1188
R.P. Wilkes et al. / Journal of Virologic
Table  3
Detection limit comparison between CPV-2 iiPCR and qPCR.
Dilutions iiPCR (result (S/N)) qPCR
−5 +(4.12) +(4.52) +(4.00) 31.53 32.91 31.93
−6 +(2.40) +(3.49) +(3.36) 35.82 35.5 34.2
−7  +(1.71) +(1.75) +(2.00) 38.96 39.57 ND
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tivity. Am.  J. Vet. Res. 47, 1464–1467.−8  −(0.99) −(1.00) −(0.98) ND ND ND
D, not detected.
ontaining 200 nM of probe and 300 nM of each primer. Samples
ere ampliﬁed in a Smart Cycler II (Cepheid, Sunnyvale, CA, USA)
ith an activation step for the hot start Taq polymerase at 95 ◦C
or 2 min, followed by 45 cycles of 95 ◦C for 15 s, 60 ◦C for 30 s, and
2 ◦C for 30 s. Analytical sensitivity of the qPCR was determined to
e 10 copies of standard plasmid DNA (data not shown). The qPCR
ad a linear dynamic range between 108 and 101 copies, with a
lope of −3.4, a y-intercept of around 39, and a mean coefﬁcient
inearity (R2) of 0.998. The reaction was validated internally to be
ore sensitive than electron microscopic detection of parvovirus
nd a commercially available ELISA (IDEXX) (data not shown).
Analytical sensitivity of CPV-2 iiPCR in detecting viral DNA was
ompared to that of the reference qPCR using serial dilutions of DNA
xtracted from a CPV-2b clinical isolate (provided by Dr. Edward
ubovi, Cornell University, Ithaca, NY, USA) run in triplicate. Limits
f detection of iiPCR and qPCR were reached at 107- and 106-
old dilution, respectively, indicating that the established reaction
ad sensitivity equivalent to, if not better than, that of the qPCR
Table 3). Furthermore, to assess the speciﬁcity of the CPV-2 iiPCR,
ne subtype 2a isolate (provided by Dr. Jeremiah T. Saliki, Athens
eterinary Diagnostic Laboratory, University of Georgia, Athens,
A, USA), four subtype 2b, and three 2c samples, identiﬁed pre-
iously by sequencing analysis, were tested. Positive results were
btained from all eight samples, demonstrating that the reagent
ould detect all current CPV subtypes. The iiPCR reagent could also
etect feline panleukopenia virus (FPV), a close relative of CPV-2.
urthermore, an exclusivity panel including nine important canine
athogens (canine adenovirus 2, canine herpesvirus, canine parain-
uenza virus, canine enteric coronavirus, canine distemper virus,
almonella enterica serovars Typhimuruim and Dublin,  Clostridium
erfringens with tox A gene, and Cryptosporidium canis) were ana-
yzed. All of them generated negative results with iiPCR, indicating
xcellent speciﬁcity of the established assay.
Performance of the established system for detecting CPV2 in
eces of animals with diarrhea was evaluated by comparing test
esults of iiPCR and the reference qPCR. Nucleic acid extracts of fecal
amples from dogs with clinical signs suggestive of CPV-2 infection
t UTVMC from 2010 to 2014 were tested in parallel. Among the
00 clinical samples, 62 were CPV-2 positive by the qPCR assay,
enerating Ct values between 10.01 and 39.19. The iiPCR did not
etect one of the qPCR-positive samples. The discrepancy between
he qPCR and iiPCR result may  be due to the very low amount of
irus in the sample (Ct = 38.00) and was likely detection of vaccine
hedding by the qPCR method. All 38 qPCR-negative samples also
ested negative by iiPCR.
Taken together, excellent agreement (k = 0.98) was found
etween iiPCR and qPCR, with sensitivity of 98.41% (conﬁ-
ence index = 93.36–100%) and speciﬁcity of 100% (conﬁdence
ndex = 93.18–100%), indicating that the iiPCR system detected
PV-2 from clinical samples with sensitivity and speciﬁcity com-
arable to those of the qPCR.
In conclusion, the results of the current study indicate that the
erformance of the CPV-2 iiPCR was equivalent to that of the ref-
rence qPCR. A positive iiPCR result is consistent with detection of
PV-2 viral DNA in the sample. On the contrary, a negative iiPCR
esult indicates that no viral DNA or an extremely low level of theal Methods 220 (2015) 35–38 37
viral DNA (below assay detection limit) is present in the sample.
Based on the sensitivity of the test, similar to qPCR assays, this assay
can detect low amounts of modiﬁed-live vaccine virus shedding
and this should be taken into consideration in recently vaccinated
animals.
The reagent was demonstrated to work in a lyophilized format,
which allowed it to be shipped and stored without refrigeration to
facilitate PON application. For resource-limited settings, both man-
ual nucleic acid extraction method (PetNADTM Co-prep, GeneReach
USA) and ﬁeld-deployable automatic nucleic acid extraction device
(TacoTM mini, GeneReach USA) are available to work with the CPV-2
iiPCR/POCKITTM system. Including the nucleic acid extraction step,
which takes about 30 min  for either method, the time required
from samples to results is around 1.5 h. In conclusion, performed
in a portable POCKITTM device, the established iiPCR reagent has
potential to serve as a useful tool for PON molecular diagnosis and
surveillance of CPV-2, a threat to animals, especially puppies in
animal shelters.
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